Skip to main content

PEPG

Stock
Health Care
Biotechnology

Performance overview

PEPG Price
Price Chart

Forward-looking statistics

Beta
1.07
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Company info

SectorHealth Care
IndustryBiotechnology
Employees64
Market cap$537.2M

Fundamentals

Enterprise value-$43.2M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity19.91

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.14
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$344K
Avg trading volume (10 day)$593K
Put-call ratio—

Macro factor sensitivity

Growth-8.3
Credit+5.9
Liquidity+4.6
Inflation-16.2
Commodities-3.2
Interest Rates+0.4

Valuation

Dividend yield0.00%
PEG Ratio-0.46
Price to sales—
P/E Ratio-0.46
Enterprise Value to Revenue—
Price to book0.43

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend dayMay 23, 2022

News

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

PepGen Inc. PEPG announced on Wednesday that it will focus on advancing its myotonic dystrophy type 1 (DM1) program, currently in Phase 2 clinical development.

Benzinga (May 29, 2025)
All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy

PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research (January 8, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free